MetaADEDB 2.0 @ LMMD
linaclotide
(KXGCNMMJRFDFNR-WDRJZQOASA-N)
Structure
SMILES
OC(=O)CC[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C)NC(=O)[C@H]4N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)O)CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC3=O)[C@H](O)C)C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)CSSC[C@@H](C(=O)N2)N)CC(=O)N)CCC4
Type(s)
Approved
ATC code(s)
A06AX04
Molecular Formula:
C59H79N15O21S6
Molecular Weight:
1526.740
Log P:
-0.5930
Hydrogen Bond Acceptor:
42
Hydrogen Bond Donor:
19
TPSA:
725.71
CAS Number(s):
851199-59-2
Synonym(s)
1.
linaclotide
2.
ASP-0456
3.
ASP0456
4.
Linaclotide Acetate
5.
Linzess
6.
MD-1100
7.
MD-1100 acetate
External Link(s)
MeSHC523483
PubChem Compound16158208
ChEBI68551
CHEMBLCHEMBL3301675
DrugBankDB08890
DrugCentral4622
KEGGdr:D09355
Therapeutic Target DatabaseD00GNJ
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1422US FAERS
2Abdominal PainFAERS: 307SIDER
US FAERS
3Intentional product misuseFAERS: 247US FAERS
4ConstipationFAERS: 226US FAERS
5Inappropriate schedule of drug administrationFAERS: 208US FAERS
6FlatulenceFAERS: 192SIDER
US FAERS
7NauseaFAERS: 141US FAERS
8Drug dose omissionFAERS: 122US FAERS
9Wrong technique in product usage processFAERS: 102US FAERS
10Product storage errorFAERS: 98US FAERS
11DizzinessFAERS: 95SIDER
US FAERS
12Abdominal discomfortFAERS: 74US FAERS
13HeadacheFAERS: 67SIDER
US FAERS
14Incorrect dose administeredFAERS: 62US FAERS
15Drug dispensing errorFAERS: 60US FAERS
16Drug ineffective for unapproved indicationFAERS: 58US FAERS
17MalaiseFAERS: 51US FAERS
18Drug prescribing errorFAERS: 49US FAERS
19VomitingFAERS: 48SIDER
US FAERS
20FatigueFAERS: 43SIDER
US FAERS
21Bowel movement irregularityFAERS: 41US FAERS
22DehydrationFAERS: 41SIDER
US FAERS
23PainFAERS: 40US FAERS
24AstheniaFAERS: 39SIDER
US FAERS
25Weight decreasedFAERS: 38US FAERS
26Expired product administeredFAERS: 35US FAERS
27Gastrointestinal motility disorderFAERS: 32US FAERS
28PruritusFAERS: 32US FAERS
29Unevaluable eventFAERS: 32US FAERS
30Feeling abnormalFAERS: 29US FAERS
31Back PainFAERS: 28US FAERS
32AlopeciaFAERS: 27US FAERS
33Product packaging quantity issueFAERS: 25US FAERS
34PalpitationsFAERS: 24US FAERS
35DyspepsiaFAERS: 23SIDER
US FAERS
36UrticariaFAERS: 23SIDER
US FAERS
37Adverse eventFAERS: 16US FAERS
38Medication ErrorFAERS: 16US FAERS
39Product physical issueFAERS: 15US FAERS
40Product quality issueFAERS: 15US FAERS
41Chest PainFAERS: 14US FAERS
42DiscomfortFAERS: 13US FAERS
43DiverticulitisFAERS: 13US FAERS
44Infrequent bowel movementsFAERS: 13US FAERS
45SomnolenceFAERS: 13US FAERS
46AnxietyFAERS: 12US FAERS
47DyscheziaFAERS: 12US FAERS
48EructationFAERS: 12US FAERS
49HypersensitivityFAERS: 12SIDER
US FAERS
50Product use in unapproved indicationFAERS: 12US FAERS
51SyncopeFAERS: 12US FAERS
52Gastrointestinal PainFAERS: 11SIDER
US FAERS
53Gastrointestinal sounds abnormalFAERS: 11US FAERS
54Incorrect product storageFAERS: 11US FAERS
55Intentional dose omissionFAERS: 11US FAERS
56Intestinal ObstructionFAERS: 11US FAERS
57Peripheral swellingFAERS: 11US FAERS
58Drug effect delayedFAERS: 10US FAERS
59MyalgiaFAERS: 10US FAERS
60SwellingFAERS: 10US FAERS
61TremorFAERS: 10US FAERS
62NervousnessFAERS: 9US FAERS
63Therapeutic response unexpectedFAERS: 9US FAERS
64Anorectal discomfortFAERS: 8US FAERS
65ChillsFAERS: 8US FAERS
66Drug effect incompleteFAERS: 8US FAERS
67Rectal tenesmusFAERS: 8US FAERS
68Accidental exposure to productFAERS: 7US FAERS
69Accidental overdoseFAERS: 7US FAERS
70Blood glucose increasedFAERS: 7US FAERS
71Burning sensationFAERS: 7US FAERS
72Electrolyte imbalanceFAERS: 7US FAERS
73Gastric DilatationFAERS: 7US FAERS
74HypotensionFAERS: 7US FAERS
75Joint swellingFAERS: 7US FAERS
76Prescription drug used without a prescriptionFAERS: 7US FAERS
77Product use issueFAERS: 7US FAERS
78AcneFAERS: 6US FAERS
79ArthralgiaFAERS: 6US FAERS
80Chest discomfortFAERS: 6US FAERS
81Clostridium difficile infectionFAERS: 6US FAERS
82ColitisFAERS: 6US FAERS
83Drug effect variableFAERS: 6US FAERS
84DysuriaFAERS: 6US FAERS
85EpistaxisFAERS: 6US FAERS
86Intentional drug misuseFAERS: 6US FAERS
87Intestinal PerforationFAERS: 6US FAERS
88OverdoseFAERS: 6US FAERS
89ThirstFAERS: 6US FAERS
90Blood potassium decreasedFAERS: 5US FAERS
91Contraindicated drug prescribedFAERS: 5US FAERS
92DysgeusiaFAERS: 5US FAERS
93ErythemaFAERS: 5US FAERS
94Feeling ColdFAERS: 5US FAERS
95FlushingFAERS: 5US FAERS
96Irritable Bowel SyndromeFAERS: 523330973CTD
US FAERS
97Lip swellingFAERS: 5US FAERS
98Oropharyngeal painFAERS: 5US FAERS
99Prescribed overdoseFAERS: 5US FAERS
100Product packaging issueFAERS: 5US FAERS
101Rectal dischargeFAERS: 5US FAERS
102SinusitisFAERS: 5SIDER
US FAERS
103Urinary IncontinenceFAERS: 5US FAERS
104VertigoFAERS: 5US FAERS
105AgitationFAERS: 4US FAERS
106Blood sodium decreasedFAERS: 4US FAERS
107Drug administration errorFAERS: 4US FAERS
108GastritisFAERS: 4US FAERS
109Poor quality drug administeredFAERS: 4US FAERS
110PresyncopeFAERS: 4US FAERS
111Therapeutic response delayedFAERS: 4US FAERS
112TinnitusFAERS: 4US FAERS
113Visual ImpairmentFAERS: 4US FAERS
114treatment failureFAERS: 4US FAERS
115Back disorderFAERS: 3US FAERS
116Bladder discomfortFAERS: 3US FAERS
117Bladder painFAERS: 3US FAERS
118Blood glucose decreasedFAERS: 3US FAERS
119Contraindicated product administeredFAERS: 3US FAERS
120Dry skinFAERS: 3US FAERS
121HerniaFAERS: 3US FAERS
122HungerFAERS: 3US FAERS
123IncontinenceFAERS: 3US FAERS
124InfluenzaFAERS: 3US FAERS
125LethargyFAERS: 3US FAERS
126MydriasisFAERS: 3US FAERS
127NasopharyngitisFAERS: 3US FAERS
128Neck PainFAERS: 3US FAERS
129NephrolithiasisFAERS: 3US FAERS
130Product size issueFAERS: 3US FAERS
131SneezingFAERS: 3US FAERS
132SunburnFAERS: 3US FAERS
133Urinary RetentionFAERS: 3US FAERS
134Urinary tract infectionFAERS: 3US FAERS
135Abdominal rigidityFAERS: 2US FAERS
136AgeusiaFAERS: 2US FAERS
137AmnesiaFAERS: 2US FAERS
138Anal spasmFAERS: 2US FAERS
139Anaphylactic shockFAERS: 2US FAERS
140AngioedemaFAERS: 2US FAERS
141Atrial FibrillationFAERS: 2US FAERS
142Blood cholesterol increasedFAERS: 2US FAERS
143Blood creatinine increasedFAERS: 2US FAERS
144ChromaturiaFAERS: 2US FAERS
145Drug screen positiveFAERS: 2US FAERS
146DysphoniaFAERS: 2US FAERS
147Epigastric discomfortFAERS: 2US FAERS
148Extra dose administeredFAERS: 2US FAERS
149Eye painFAERS: 2US FAERS
150Feeling jitteryFAERS: 2US FAERS
151Foreign body in respiratory tractFAERS: 2US FAERS
152GastroenteritisFAERS: 2US FAERS
153Genital infection fungalFAERS: 2US FAERS
154Gluten sensitivityFAERS: 2US FAERS
155GoutFAERS: 2US FAERS
156HyperchlorhydriaFAERS: 2US FAERS
157IleusFAERS: 2US FAERS
158Impaired gastric emptyingFAERS: 2US FAERS
159Incorrect disposal of productFAERS: 2US FAERS
160Incorrect drug administration durationFAERS: 2US FAERS
161Incorrect route of drug administrationFAERS: 2US FAERS
162Intentional product use issueFAERS: 2US FAERS
163Large intestine perforationFAERS: 2US FAERS
164LaryngitisFAERS: 2US FAERS
165Loss of personal independence in daily activitiesFAERS: 2US FAERS
166Memory impairmentFAERS: 2US FAERS
167Mouth swellingFAERS: 2US FAERS
168Muscle strainFAERS: 2US FAERS
169Musculoskeletal PainFAERS: 2US FAERS
170NeuralgiaFAERS: 2US FAERS
171PancreatitisFAERS: 2US FAERS
172PregnancyFAERS: 2US FAERS
173Product dose omissionFAERS: 2US FAERS
174Product solubility abnormalFAERS: 2US FAERS
175Productive CoughFAERS: 2US FAERS
176Renal painFAERS: 2US FAERS
177Sense of oppressionFAERS: 2US FAERS
178StomatitisFAERS: 2US FAERS
179StressFAERS: 2US FAERS
180TachyphylaxisFAERS: 2US FAERS
181Therapy changeFAERS: 2US FAERS
182Urine flow decreasedFAERS: 2US FAERS
183jaundiceFAERS: 2US FAERS
184Abdominal tendernessFAERS: 1US FAERS
185Abnormal weight gainFAERS: 1US FAERS
186Accidental exposure to product by childFAERS: 1US FAERS
187Acute kidney injuryFAERS: 1US FAERS
188Acute psychosisFAERS: 1US FAERS
189Ammonia increasedFAERS: 1US FAERS
190Anal FissureFAERS: 1US FAERS
191Anal inflammationFAERS: 1US FAERS
192AngerFAERS: 1US FAERS
193Angina PectorisFAERS: 1US FAERS
194Anginal equivalentFAERS: 1US FAERS
195AnuriaFAERS: 1US FAERS
196Aphthous StomatitisFAERS: 1US FAERS
197Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
198AtaxiaFAERS: 1US FAERS
199Atrioventricular BlockFAERS: 1US FAERS
200Autoimmune hepatitisFAERS: 1US FAERS
201Biliary ColicFAERS: 1US FAERS
202Blood chloride decreasedFAERS: 1US FAERS
203Blood creatinine decreasedFAERS: 1US FAERS
204Blood electrolytes decreasedFAERS: 1US FAERS
205Blood iron decreasedFAERS: 1US FAERS
206Blood potassium increasedFAERS: 1US FAERS
207Blood sodium increasedFAERS: 1US FAERS
208Blood urine presentFAERS: 1US FAERS
209Blunted affectFAERS: 1US FAERS
210Bone painFAERS: 1US FAERS
211Breast tendernessFAERS: 1US FAERS
212Butterfly rashFAERS: 1US FAERS
213Cardiac ArrestFAERS: 1US FAERS
214Cardiac FlutterFAERS: 1US FAERS
215Cerebrovascular accidentFAERS: 1US FAERS
216ChloasmaFAERS: 1US FAERS
217ChokingFAERS: 1US FAERS
218CholecystitisFAERS: 1US FAERS
219Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
220Clostridium test positiveFAERS: 1US FAERS
221ColectomyFAERS: 1US FAERS
222Contraindicated product prescribedFAERS: 1US FAERS
223Creatinine renal clearance increasedFAERS: 1US FAERS
224CystitisFAERS: 1US FAERS
225DeafnessFAERS: 1US FAERS
226Depressed Level of ConsciousnessFAERS: 1US FAERS
227Depressed moodFAERS: 1US FAERS
228DiplopiaFAERS: 1US FAERS
229DisabilityFAERS: 1US FAERS
230DiverticulumFAERS: 1US FAERS
231Drug DependenceFAERS: 1US FAERS
232Drug administered to patient of inappropriate ageFAERS: 1US FAERS
233Drug resistanceFAERS: 1US FAERS
234Drug screen false positiveFAERS: 1US FAERS
235Drug screen negativeFAERS: 1US FAERS
236Drug withdrawal syndromeFAERS: 1US FAERS
237Ear discomfortFAERS: 1US FAERS
238Early satietyFAERS: 1US FAERS
239Eating disorder symptomFAERS: 1US FAERS
240Electrolyte depletionFAERS: 1US FAERS
241Emotional disorderFAERS: 1US FAERS
242Emotional distressFAERS: 1US FAERS
243Emotional povertyFAERS: 1US FAERS
244EndometriosisFAERS: 1US FAERS
245Eye irritationFAERS: 1US FAERS
246Eyelid painFAERS: 1US FAERS
247Facial PainFAERS: 1US FAERS
248Failure to ThriveFAERS: 1US FAERS
249Food aversionFAERS: 1US FAERS
250Food cravingFAERS: 1US FAERS
251Gastric ulcerFAERS: 1US FAERS
252Gastrointestinal carcinomaFAERS: 1US FAERS
253Gastrointestinal hypermotilityFAERS: 1US FAERS
254Gastrointestinal hypomotilityFAERS: 1US FAERS
255Gastrointestinal inflammationFAERS: 1US FAERS
256Gastrointestinal obstructionFAERS: 1US FAERS
257General physical health deteriorationFAERS: 1US FAERS
258Genital discomfortFAERS: 1US FAERS
259Hair injuryFAERS: 1US FAERS
260Head BangingFAERS: 1US FAERS
261Head discomfortFAERS: 1US FAERS
262Heat StrokeFAERS: 1US FAERS
263Herpes Zoster OticusFAERS: 1US FAERS
264HypersomniaFAERS: 1US FAERS
265HypophagiaFAERS: 1US FAERS
266HysterectomyFAERS: 1US FAERS
267Immune thrombocytopenic purpuraFAERS: 1US FAERS
268Impaired work abilityFAERS: 1US FAERS
269Increased upper airway secretionFAERS: 1US FAERS
270Inhibitory drug interactionFAERS: 1US FAERS
271Intercepted drug prescribing errorFAERS: 1US FAERS
272Intervertebral disc injuryFAERS: 1US FAERS
273Intestinal congestionFAERS: 1US FAERS
274Irregular breathingFAERS: 1US FAERS
275Maternal exposure during breast feedingFAERS: 1US FAERS
276Medical dietFAERS: 1US FAERS
277Medication residue presentFAERS: 1US FAERS
278Middle insomniaFAERS: 1US FAERS
279Multiple SclerosisFAERS: 1US FAERS
280Muscular DystrophyFAERS: 1US FAERS
281Musculoskeletal chest painFAERS: 1US FAERS
282Musculoskeletal stiffnessFAERS: 1US FAERS
283Myocardial InfarctionFAERS: 1US FAERS
284Nasal discomfortFAERS: 1US FAERS
285Night sweatsFAERS: 1US FAERS
286Nipple painFAERS: 1US FAERS
287NoduleFAERS: 1US FAERS
288Non-cardiac chest painFAERS: 1US FAERS
289Nutritional condition abnormalFAERS: 1US FAERS
290ObesityFAERS: 1US FAERS
291OnychoclasisFAERS: 1US FAERS
292Parenteral NutritionFAERS: 1US FAERS
293Pelvic PainFAERS: 1US FAERS
294Penile swellingFAERS: 1US FAERS
295Peripheral motor neuropathyFAERS: 1US FAERS
296Physical disabilityFAERS: 1US FAERS
297PneumoniaFAERS: 1US FAERS
298PolyuriaFAERS: 1US FAERS
299Prescribed underdoseFAERS: 1US FAERS
300ProctitisFAERS: 1US FAERS
301Product container issueFAERS: 1US FAERS
302Product contamination physicalFAERS: 1US FAERS
303Product formulation issueFAERS: 1US FAERS
304Product use complaintFAERS: 1US FAERS
305Protein total decreasedFAERS: 1US FAERS
306Pulmonary EmbolismFAERS: 1US FAERS
307Pyruvate kinase increasedFAERS: 1US FAERS
308Rash erythematousFAERS: 1US FAERS
309Reaction to preservativesFAERS: 1US FAERS
310Rectal spasmFAERS: 1US FAERS
311Reduced bladder capacityFAERS: 1US FAERS
312Renal ColicFAERS: 1US FAERS
313Renal cystFAERS: 1US FAERS
314Restless Legs SyndromeFAERS: 1US FAERS
315RestlessnessFAERS: 1US FAERS
316RetchingFAERS: 1US FAERS
317Saliva alteredFAERS: 1US FAERS
318Secretion dischargeFAERS: 1US FAERS
319SepsisFAERS: 1US FAERS
320Sexual DysfunctionFAERS: 1US FAERS
321Skin WrinklingFAERS: 1US FAERS
322Skin lesionFAERS: 1US FAERS
323Skin reactionFAERS: 1US FAERS
324Skin tightnessFAERS: 1US FAERS
325SomnambulismFAERS: 1US FAERS
326Stoma obstructionFAERS: 1US FAERS
327Suicide attemptFAERS: 1US FAERS
328TachycardiaFAERS: 1US FAERS
329Temperature intoleranceFAERS: 1US FAERS
330TetanyFAERS: 1US FAERS
331Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
332Throat cancerFAERS: 1US FAERS
333ThrombocytopeniaFAERS: 1US FAERS
334Tongue blisteringFAERS: 1US FAERS
335TrichorrhexisFAERS: 1US FAERS
336Trisomy 21FAERS: 1US FAERS
337UlcerFAERS: 1US FAERS
338Unresponsive to stimuliFAERS: 1US FAERS
339Urinary hesitationFAERS: 1US FAERS
340Urine output increasedFAERS: 1US FAERS
341VasculitisFAERS: 1US FAERS
342Vitamin D DeficiencyFAERS: 1US FAERS
343VitiligoFAERS: 1US FAERS
344Vitreous floatersFAERS: 1US FAERS
345Vulvovaginal burning sensationFAERS: 1US FAERS
346Vulvovaginal painFAERS: 1US FAERS
347WheezingFAERS: 1US FAERS
348Wound ComplicationFAERS: 1US FAERS
349YawningFAERS: 1US FAERS
350DermatitisSIDER
351InfectionSIDER
352InfestationSIDER
353MalnutritionSIDER
354nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.